This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
A minorities-only study on a dual-action therapy for diabetic macular edema found Hispanic and Latino patients not only appear to experience more severe disease but also may derive a greater benefit from on-label treatment.
Medscape Medical News